29Jun 2023
Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus

Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus

The study examined the relationship between hyperuricemia (HUA) and metabolic dysfunction-associated fatty liver disease (MAFLD) in nonobese patients without type 2 diabetes mellitus (T2DM). The study included 28,187 participants and found that HUA was positively associated with MAFLD in both males and females. This association persisted even after adjusting for other factors such as sex, BMI, dyslipidemia, and abnormal liver function. The association between HUA and MAFLD was more prominent in individuals over 40 years old. The study suggests that abnormalities in uric acid levels should be considered in diagnosing MAFLD in nonobese patients without T2DM.

  • #endo-diabetology

Like

Save

Share